anibamine: a pyridine quaternary alkaloid from Aniba sp.; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Flora | Rank | Flora Definition | Family | Family Definition |
---|---|---|---|---|
Aniba | genus | [no description available] | Lauraceae | A family of mainly aromatic evergreen plants in the order Laurales. The laurel family includes 2,200 species in 45 genera and from these are derived medicinal extracts, essential oils, camphor and other products.[MeSH] |
ID Source | ID |
---|---|
PubMed CID | 6479877 |
CHEMBL ID | 469649 |
CHEMBL ID | 1186558 |
MeSH ID | M0470207 |
Synonym |
---|
anibamine |
1h-indolizinium, 6,8-di-(1z)-1-decenyl-2,3-dihydro-5,7-dimethyl- |
6,8-bis[(z)-dec-1-enyl]-5,7-dimethyl-2,3-dihydro-1h-indolizin-4-ium |
bdbm50242053 |
6,8-didec-(1z)-enyl-5,7-dimethyl-2,3-dihydro-1h-indolizinium trifluoroacetic acid salt |
CHEMBL469649 , |
CHEMBL1186558 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 6 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (23.91) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 9 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |